Naoto T Ueno
Naoto T Ueno
University of Hawaiʻi Cancer Center
Dirección de correo verificada de - Página principal
Citado por
Citado por
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer
S Modi, W Jacot, T Yamashita, J Sohn, M Vidal, E Tokunaga, J Tsurutani, ...
New England Journal of Medicine 387 (1), 9-20, 2022
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for …
IF Khouri, M Keating, M Körbling, D Przepiorka, P Anderlini, S O'Brien, ...
Journal of Clinical Oncology 16 (8), 2817-2824, 1998
Genome evolution in the allotetraploid frog Xenopus laevis
AM Session, Y Uno, T Kwon, JA Chapman, A Toyoda, S Takahashi, ...
Nature 538 (7625), 336-343, 2016
Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes
H Masuda, KA Baggerly, Y Wang, Y Zhang, AM Gonzalez-Angulo, ...
Clinical cancer research 19 (19), 5533-5540, 2013
Bone imaging in metastatic breast cancer
T Hamaoka, JE Madewell, DA Podoloff, GN Hortobagyi, NT Ueno
Journal of Clinical Oncology 22 (14), 2942-2953, 2004
Role of epidermal growth factor receptor in breast cancer
H Masuda, D Zhang, C Bartholomeusz, H Doihara, GN Hortobagyi, ...
Breast cancer research and treatment 136, 331-345, 2012
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
DJ McGrail, PG Pilié, NU Rashid, L Voorwerk, M Slagter, M Kok, ...
Annals of Oncology 32 (5), 661-672, 2021
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell …
S Giralt, PF Thall, I Khouri, X Wang, I Braunschweig, C Ippolitti, D Claxton, ...
Blood, The Journal of the American Society of Hematology 97 (3), 631-637, 2001
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
C Hatzis, L Pusztai, V Valero, DJ Booser, L Esserman, A Lluch, T Vidaurre, ...
Jama 305 (18), 1873-1881, 2011
Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo
S Iemura, TS Yamamoto, C Takagi, H Uchiyama, T Natsume, S Shimasaki, ...
Proceedings of the National Academy of Sciences 95 (16), 9337-9342, 1998
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ...
Annals of oncology 22 (3), 515-523, 2011
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors
N Niikura, J Liu, N Hayashi, EA Mittendorf, Y Gong, SL Palla, Y Tokuda, ...
Journal of Clinical Oncology 30 (6), 593, 2012
Inflammatory breast cancer: the disease, the biology, the treatment
FM Robertson, M Bondy, W Yang, H Yamauchi, S Wiggins, S Kamrudin, ...
CA: a cancer journal for clinicians 60 (6), 351-375, 2010
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term …
M De Lima, A Anagnostopoulos, M Munsell, M Shahjahan, N Ueno, ...
Blood 104 (3), 865-872, 2004
Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials
F Meric-Bernstam, L Brusco, K Shaw, C Horombe, S Kopetz, MA Davies, ...
Journal of clinical oncology 33 (25), 2753, 2015
P27kip1 down-regulation is associated with trastuzumab resistance in breast cancer cells
R Nahta, T Takahashi, NT Ueno, MC Hung, FJ Esteva
Cancer research 64 (11), 3981-3986, 2004
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and …
IF Khouri, P McLaughlin, RM Saliba, C Hosing, M Korbling, MS Lee, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5530-5536, 2008
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
NT Ueno, G Rondón, NQ Mirza, DK Geisler, P Anderlini, SA Giralt, ...
Journal of clinical oncology 16 (3), 986-993, 1998
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at MD Anderson Cancer Center
NT Ueno, AU Buzdar, SE Singletary, FC Ames, MD McNeese, FA Holmes, ...
Cancer chemotherapy and pharmacology 40, 321-329, 1997
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20